Product
Supplier
Encyclopedia
Inquiry
Home > News > Company Dynamic > Stunning NZ$1.24 Billion Acquisition! Stonepeak Acquires New Zealand Retirement Giant Arvida, Sending Stock Price Soaring by 60%

Stunning NZ$1.24 Billion Acquisition! Stonepeak Acquires New Zealand Retirement Giant Arvida, Sending Stock Price Soaring by 60%

ECHEMI 2024-07-22

The internationally renowned private equity firm Stonepeak, headquartered in the United States, has recently announced a shocking market transaction: they will fully acquire Arvida Group, the leading company in New Zealand's retirement services industry, for a staggering NZ$1.24 billion (approximately $754.74 million). This news is like a spring breeze, injecting new vitality into the stock prices of Stonepeak and Arvida, pushing Arvida's share price to soar nearly 60% on Monday, reaching a new high in more than two years.

 

Stonepeak, a behemoth managing around $71.2 billion in assets, has offered to acquire Arvida at NZ$1.70 per share, a premium of up to 65% over Arvida's last closing price on the previous Friday. This all-cash acquisition plan has received the full support of Arvida's board of directors, and Arvida has stated that the transaction is not subject to any financing or due diligence conditions, demonstrating the firm confidence and determination of both parties.

 

In a statement, Stonepeak further stated that considering the debt factor, Arvida's enterprise value will reach $1.25 billion. This figure not only affirms Arvida's market value but also reflects a positive outlook on its future potential. "Leveraging its well-established diversified portfolio, unique development channels, and long-term market demand, Arvida presents an unparalleled investment opportunity for our Asia infrastructure strategy," said Darren Keogh, a senior managing director at Stonepeak, who also emphasized that New Zealand's aging population trend provides Arvida with exceptional conditions for development, making it a star company in the market.

 

Following the announcement, Arvida's share price soared rapidly, rising by 57.3% and ultimately settling at NZ$1.62, a new high since June 3, 2022. Simultaneously, competitors such as Ryman Healthcare and Summerset were also enthusiastically pursued by the market, with their stock prices increasing by 7.7% and 2.25%, respectively. Industry insiders analyze that this series of stock price fluctuations suggests that the retirement services industry may be entering a new round of consolidation and restructuring.

 

It is worth mentioning that in December last year, Arvida had received a takeover offer of NZ$1.70 per share from an offshore infrastructure fund. However, due to the many stringent conditions of the offer, which did not align with the best interests of shareholders, Arvida ultimately chose to reject it. In contrast, Stonepeak's acquisition offer is markedly different, winning Arvida's favor with a compelling valuation and an extremely high degree of certainty.

 

Although there are rumors that Stonepeak may have been the company that previously proposed to privatize Arvida, Reuters currently cannot verify this information. Nonetheless, regardless of the truth, this acquisition case undoubtedly brings profound insights and changes to the retirement services industry. As the trend of population aging intensifies, the market demand for retirement services will continue to grow. Heavyweight enterprises like Stonepeak will also continue to seek more promising investment opportunities to drive the industry's sustainable development and innovation.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.

Looking for chemical products? Let suppliers reach out to you!

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.